Watch CCM alum Leigh Ann Larkin on hit CBS TV series ‘Blue Bloods’
Musical Theatre alumna Leigh Ann Larkin wears UC swag in the latest episode of the TV drama
University of Cincinnati College-Conservatory of Music alumna Leigh Ann Larkin, née Wielgus (BFA Musical Theatre, '02) showed off her Cincinnati pride in the latest episode of the CBS television series "Blue Bloods." Larkin has a recurring role as medical examiner Megan Carson on the hit drama and her character appeared in a UC hoodie in the April 3 episode entitled "The Puzzle Palace."
The full episode is available for streaming on CBS' website.
Leigh Ann Larkin wears a hoodie from the UC Bookstore in the April 3 episode of "Blue Bloods." Photo/CBS Television Studios
Larkin originated her role on "Blue Bloods" in the 2019 episode "My Brother's Keeper." Now in its tenth season, the police procedural drama stars Tom Selleck and Donnie Wahlberg. Larkin made her TV acting debut in a 2008 episode of "Lipstick Jungle" and has since appeared in "The Flight of the Conchords," "Elementary," "The Good Wife" and "NCIS: New Orleans."
In 2008 Larkin made her Broadway debut in the role of Dainty June in “Gypsy.” She also played the role of Petra in the 2009 revival of “A Little Night Music,” starring Angela Lansbury and Catherine Zeta-Jones.
Learn more about Larkin’s current and upcoming projects by visiting her website.
Featured image at the top: Tom Selleck in "Blue Bloods." Photo/CBS Television Studios
Related Stories
UC's art collection on display at the Contemporary Arts Center
January 5, 2026
University of Cincinnati leaders joined WVXU's Cincinnati Edition to talk about the university’s 200-year-old art collection, a new exhibition at the Contemporary Arts Center and the release of a companion book exploring the collection’s role in education and public engagement.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.